Brief: Galapagos Announces Board Decision To Initiate Wind-Down Of Cell Therapy Activities
05/01/2026 22:14
Galapagos NV GLPG.AS: GALAPAGOS ANNOUNCES BOARD DECISION TO INITIATE WIND-DOWN OF CELL THERAPY ACTIVITIES GALAPAGOS NV - WIND-DOWN IMPACTS ABOUT 365 EMPLOYEES GALAPAGOS NV - CLOSURE OF SITES IN LEIDEN, BASEL, PRINCETON, PITTSBURGH, SHANGHAI Source text: ID:nGNX1KNcHd Further company coverage: GLPG.AS
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline